
Transactions: Healthcare
Filter


Redemption offer in Medivir (SE) — SEK 625 million

Block trade of shares in Recipharm (SE) — SEK 425 million

Rights issue in Hansa Medical AB (SE) — SEK 246 million

Secondary placing of shares in Recipharm (SE) — SEK 269 million


Acquisition of CDMO Lusomedicamenta Sociedade Técnica Farmacêutica S.A. (PT) by Recipharm AB (SE) — Enterprise value SEK 1 billion

Initial public offering of Lifco (SE) on NASDAQ Stockholm – SEK 4.2 billion

Rights issue in Oasmia Pharmaceutical AB (SE) — SEK 176 million

Directed new share issue in Weifa ASA (NO) – NOK 115 million

Initial public offering of NEXT Biometrics Group ASA (NO) on the Oslo Axess — NOK 233 million

Senior secured bond issue by Weifa ASA (formerly Aqualis ASA) (NO) – NOK 400 million
